AU758464B2 - HIV nuclear localization inhibitors - Google Patents

HIV nuclear localization inhibitors Download PDF

Info

Publication number
AU758464B2
AU758464B2 AU89054/98A AU8905498A AU758464B2 AU 758464 B2 AU758464 B2 AU 758464B2 AU 89054/98 A AU89054/98 A AU 89054/98A AU 8905498 A AU8905498 A AU 8905498A AU 758464 B2 AU758464 B2 AU 758464B2
Authority
AU
Australia
Prior art keywords
compound
branched
straight
hiv
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU89054/98A
Other languages
English (en)
Other versions
AU8905498A (en
Inventor
Michael Bukrinsky
David Callaway
Omar K Haffar
Senliang Pan
Peter Ulrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Picower Institute for Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Picower Institute for Medical Research filed Critical Picower Institute for Medical Research
Publication of AU8905498A publication Critical patent/AU8905498A/en
Application granted granted Critical
Publication of AU758464B2 publication Critical patent/AU758464B2/en
Assigned to CYTOKINE PHARMASCIENCES, INC. reassignment CYTOKINE PHARMASCIENCES, INC. Alteration of Name(s) in Register under S187 Assignors: PICOWER INSTITUTE FOR MEDICAL RESEARCH, THE
Assigned to FERRING B.V. reassignment FERRING B.V. Alteration of Name(s) in Register under S187 Assignors: CYTOKINE PHARMASCIENCES, INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU89054/98A 1997-08-15 1998-08-13 HIV nuclear localization inhibitors Ceased AU758464B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/912076 1997-08-15
US08/912,076 US5808068A (en) 1997-08-15 1997-08-15 HIV nuclear localization inhibitors
PCT/US1998/016814 WO1999009014A1 (en) 1997-08-15 1998-08-13 Hiv nuclear localization inhibitors

Publications (2)

Publication Number Publication Date
AU8905498A AU8905498A (en) 1999-03-08
AU758464B2 true AU758464B2 (en) 2003-03-20

Family

ID=25431342

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89054/98A Ceased AU758464B2 (en) 1997-08-15 1998-08-13 HIV nuclear localization inhibitors

Country Status (8)

Country Link
US (1) US5808068A (https=)
EP (1) EP1012146B1 (https=)
JP (1) JP4475487B2 (https=)
AT (1) ATE245983T1 (https=)
AU (1) AU758464B2 (https=)
CA (1) CA2300424C (https=)
DE (1) DE69816835T2 (https=)
WO (1) WO1999009014A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297253B1 (en) * 1996-10-15 2001-10-02 The Picower Institute For Medical Research Compounds and methods of use to treat infectious diseases
CA2686618A1 (en) * 2003-07-17 2005-01-17 At&T Corp. Method and apparatus for windowing in entropy encoding
US20050203150A1 (en) * 2004-03-09 2005-09-15 Haffar Omar K. Compounds, compositions and methods for inhibiting or treating HIV-1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0673022A (ja) * 1992-08-27 1994-03-15 Kumiai Chem Ind Co Ltd ピリミジンまたはトリアジン誘導体及び除草剤

Also Published As

Publication number Publication date
JP4475487B2 (ja) 2010-06-09
CA2300424C (en) 2009-04-07
WO1999009014A1 (en) 1999-02-25
EP1012146A1 (en) 2000-06-28
EP1012146A4 (en) 2002-12-04
EP1012146B1 (en) 2003-07-30
DE69816835T2 (de) 2004-04-22
DE69816835D1 (de) 2003-09-04
ATE245983T1 (de) 2003-08-15
JP2001515069A (ja) 2001-09-18
US5808068A (en) 1998-09-15
AU8905498A (en) 1999-03-08
CA2300424A1 (en) 1999-02-25

Similar Documents

Publication Publication Date Title
Selvam et al. Synthesis and anti-HIV activity of 4-[(1, 2-dihydro-2-oxo-3H-indol-3-ylidene) amino]-N (4, 6-dimethyl-2-pyrimidinyl)-benzene sulfonamide and its derivatives
Tanaka et al. Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogs of 1-[(2-hydroxyethoxy) methyl]-6-(phenylthio) thymine (HEPT)
CN101355939A (zh) 用于抑制hiv复制的新物质的组合物和合成
US5733932A (en) Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
JPH04300834A (ja) Ｈｉｖ逆転写酵素阻害剤の相乗作用
JPH04230280A (ja) アミノベンゾジアゼピン類およびそれを含有している薬剤
WO1997038999A9 (en) Acridone-derived compounds useful as antineoplastic and antiretroviral agents
AU759210B2 (en) HIV matrix protein tyrosine position 29 pocket binders
AU758464B2 (en) HIV nuclear localization inhibitors
JP2021500401A (ja) 広域スペクトルの抗ウイルス組成物及び方法
US6001871A (en) Hypoestoxides, derivatives and agonists thereof for use as antiviral agents
EP0843663B9 (fr) 4-aryl-thio-pyridin-2(1h)-ones, medicaments les contenant et leurs utilisations dans le traitement de maladies liees aux vih
HUP9903526A2 (hu) Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
US5574040A (en) Pyrimidine compounds and methods of use to derivatize neighboring lysine residues in proteins under physiologic conditions
US20170267726A1 (en) Non-immunosuppressive cyclosporin derivatives as antiviral agents
US20060148849A1 (en) Quinoline derivatives, process of synthesis and medicaments containing these derivatives
Michne et al. Keto/enol epoxy steroids: A new structural class of hiv-1 tat inhibitors
CN111995622B (zh) 化合物及其用途
EP2163553A1 (en) Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
CN115403625A (zh) S-DACOs类非核苷类逆转录酶抑制剂衍生物及其用途
WO2005016343A1 (en) Novel anti-viral agents based upon derivatives of the aromatic heterocycle phenanthridine
Kasralikar et al. Month 2018 Design and Synthesis of Novel 1, 2, 3-triazolyl-pyrimidinone Hybrids as Potential Anti-HIV-1 NNRT Inhibitors
US6414004B1 (en) 3-substituted 5-aryl-4-isoxazolecarbonitriles having antiviral activity
CA2525550C (en) Acridone-derived compounds useful as antiretroviral agents
CN101343303B (zh) 一种治疗艾滋病的药物化合物及其制备方法和应用

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: ADD INVENTORS DAVID CALLAWAY AND PETER ULRICH

FGA Letters patent sealed or granted (standard patent)